Cargando…

Neurodegenerative Disease and the NLRP3 Inflammasome

The prevalence of neurodegenerative disease has increased significantly in recent years, and with a rapidly aging global population, this trend is expected to continue. These diseases are characterised by a progressive neuronal loss in the brain or peripheral nervous system, and generally involve pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holbrook, Jonathan A., Jarosz-Griffiths, Heledd H., Caseley, Emily, Lara-Reyna, Samuel, Poulter, James A., Williams-Gray, Caroline H., Peckham, Daniel, McDermott, Michael F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987926/ https://www.ncbi.nlm.nih.gov/pubmed/33776778 http://dx.doi.org/10.3389/fphar.2021.643254

Ejemplares similares

Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations
por: Lara-Reyna, Samuel, et al.
Publicado: (2020)

ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis
por: Scambler, Thomas, et al.
Publicado: (2019)

Tumour necrosis factor signalling in health and disease
por: Holbrook, Jonathan, et al.
Publicado: (2019)

Metabolic Reprograming of Cystic Fibrosis Macrophages via the IRE1α Arm of the Unfolded Protein Response Results in Exacerbated Inflammation
por: Lara-Reyna, Samuel, et al.
Publicado: (2019)

An Atypical Autoinflammatory Disease Due to an LRR Domain NLRP3 Mutation Enhancing Binding to NEK7
por: Caseley, Emily A., et al.
Publicado: (2021)

Inflammasome activation: from molecular mechanisms to autoinflammation
por: Lara‐Reyna, Samuel, et al.
Publicado: (2022)

Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis
por: Jarosz-Griffiths, Heledd H, et al.
Publicado: (2020)

The role of the NLRP3 inflammasome in gout
por: Kingsbury, Sarah R, et al.
Publicado: (2011)

The role of NLRP3 inflammasome in hepatocellular carcinoma
por: Zhao, Huijie, et al.
Publicado: (2023)

NLRP3 inflammasome and its inhibitors: a review
por: Shao, Bo-Zong, et al.
Publicado: (2015)

Activation of Platelet NLRP3 Inflammasome in Crohn’s Disease
por: Zhang, Ge, et al.
Publicado: (2021)

Pharmacological intervention of curcumin via the NLRP3 inflammasome in ischemic stroke
por: Du, Xiaoxue, et al.
Publicado: (2023)

Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis
por: Ding, Nan, et al.
Publicado: (2020)

MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies
por: Tezcan, Gulcin, et al.
Publicado: (2019)

Role of NLRP3 Inflammasome in Lupus Nephritis and Therapeutic Targeting by Phytochemicals
por: Wu, Dantong, et al.
Publicado: (2021)

The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets
por: Liang, Tao, et al.
Publicado: (2022)

Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1
por: Pinar, Anita A., et al.
Publicado: (2020)

Role of the NLRP3 inflammasome in neurodegenerative diseases and therapeutic implications
por: Duan, Yanhui, et al.
Publicado: (2020)

Amentoflavone Affects Epileptogenesis and Exerts Neuroprotective Effects by Inhibiting NLRP3 Inflammasome
por: Rong, Shikuo, et al.
Publicado: (2019)

Targeting NLRP3 Inflammasome in Translational Treatment of Nervous System Diseases: An Update
por: Yu, Qingying, et al.
Publicado: (2021)

Plant-derived bioactive compounds regulate the NLRP3 inflammasome to treat NAFLD
por: Huang, Qian, et al.
Publicado: (2022)

Yupingfeng San Inhibits NLRP3 Inflammasome to Attenuate the Inflammatory Response in Asthma Mice
por: Liu, Xue, et al.
Publicado: (2017)

Lack of the Nlrp3 Inflammasome Improves Mice Recovery Following Traumatic Brain Injury
por: Irrera, Natasha, et al.
Publicado: (2017)

Fisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome
por: Dong, Wenmin, et al.
Publicado: (2022)

Natural Products as a Novel Therapeutic Strategy for NLRP3 Inflammasome-Mediated Gout
por: Lee, Jun Ho, et al.
Publicado: (2022)

Pharmacological effects of Chinese medicine modulating NLRP3 inflammasomes in fatty liver treatment
por: Liu, Tingting, et al.
Publicado: (2022)

The NLRP3 inflammasome is involved in resident intruder paradigm-induced aggressive behaviors in mice
por: Yu, Qingying, et al.
Publicado: (2023)

Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
por: Guan, Yadi, et al.
Publicado: (2020)

The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models
por: Palumbo, Laura, et al.
Publicado: (2023)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

Scutellarin Suppresses NLRP3 Inflammasome Activation in Macrophages and Protects Mice against Bacterial Sepsis
por: Liu, Yi, et al.
Publicado: (2018)

CRP-Induced NLRP3 Inflammasome Activation Increases LDL Transcytosis Across Endothelial Cells
por: Bian, Fang, et al.
Publicado: (2019)

Sinapine Thiocyanate Ameliorates Vascular Endothelial Dysfunction in Hypertension by Inhibiting Activation of the NLRP3 Inflammasome
por: Liu, Yang, et al.
Publicado: (2021)

C646 Protects Against DSS-Induced Colitis Model by Targeting NLRP3 Inflammasome
por: Xu, Xueming, et al.
Publicado: (2021)

The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
por: Yu, Lili, et al.
Publicado: (2022)

Bletilla striata Polysaccharide Promotes Diabetic Wound Healing Through Inhibition of the NLRP3 Inflammasome
por: Zhao, Yan, et al.
Publicado: (2021)

Zerumbone Suppresses the LPS-Induced Inflammatory Response and Represses Activation of the NLRP3 Inflammasome in Macrophages
por: Su, Chia-Cheng, et al.
Publicado: (2021)

IIIM-941, a Stilbene Derivative Inhibits NLRP3 Inflammasome Activation by Inducing Autophagy
por: Ali, Mehboob, et al.
Publicado: (2021)

Emerging trends and hot spots of NLRP3 inflammasome in neurological diseases: A bibliometric analysis
por: Yu, Xiaoyan, et al.
Publicado: (2022)

Flurbiprofen inhibits heme induced NLRP3 inflammasome in Berkeley sickle cell disease mice
por: Kour, Dilpreet, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gk21lv913s5v22pe4dsb1jdqt0